Quality is our legacy     
.
Site Language
.
.

.
 Search 
   Home
 
SEDICO Company
About SEDICO
News and Reports
Worldwide Presence
Careers at SEDICO
 
SEDICO products
Products List
Strategic Brands
Search for a product
 
Social Contribution
Diabetes Center
R&D
Caring for community
Access for medicines
 
Contact SEDICO
Contact Us
Distributors Log in
Partners Log in
Vendors Log in
Physicians Log in
Patients Log in
 
SEDICO Newsletter
Subscribe to SEDICO News

    Enter Your E-mail
 

Physician
Patient

SEDICO is the pioneer in the field of Molecular Biology in the Middle East and Egypt, Manufacturing growthhormone,humanInsulin,Urokinase,Streptokinase,Erythropoetin,etc.
SEDICO is committed to provide the highest quality medicine with affordable prices.
 
ANGIKINASE
(Vial)
 

Composition:

Urokinase I.U....100,000 or 250,000 or 500,000 I.U.
 
Angikinase vial
Properties:
Angikinase is indicated in cases of:
Pulmonary embolism
Coronary artery thrombosis and myocardial infarction
Deep venous thrombosis (or venous thrombo-embolism)
Peripheral arterial thrombo-embolism
Some cases of peritonitis.
 
Dosage and administration:
In cases of Pulmonary Embolism and Deep Venous Thrombosis:
 

Priming infusion dose

4400 IU/ Kg at a rate of 90 ml /hr

Followed by

Continuous infusion dose

4400 IU Kg at a rate of 15 ml / hr over a period of 12 hrs


►►Coronary artery Thrombosis and Myocardial Infarction:
Intracoronary Route:
Before the administration of urokinase prior bolus 2500 – 10,000 Units of heparin should be administered through intravenous administration.
Reconstitute three vials of Angikinase 250,000 IU by aseptically adding 5 ml of sterile water for injection.
Then Angikinase is infused at a rate of 4ml /min into the occluded artery for a period up to 2 hours.

Intravenous route:
Angikinase is also administered at doses of 2 -3million units over 45 – 90 minutes.

►►Peripheral arterial- thromboembolism :
Urokinase is infused in the clot via a catheter at a rate of 4000 IU / min and the catheter is advanced every 2 hours till flow is resumed .then at a rate of 1000 IU / min till complete clot lysis occurs.

N.B: Preparation of reconstituted material
1. it is important to reconstitute only with sterile water for injection for injection without preservatives
2. Do not use bacteriostatic water for injection.
3. To minimize the formation of filaments avoid shaking the vial during reconstitution. Only Roll and tilt the vial during reconstitution.
4. Do not add other medications to the solution.
5. Because urokinase contains no preservatives do not reconstitute until immediately before use.
6. Discard any unused portion of the reconstituted material.
 

Warning:
Keep your tablets in the pack in which they were supplied.
Keep your tablets below 30°C.
Keep your tablets in a safe place where children cannot see or reach them.
 
Packing:
Box containing one vial of urokinase 100,000, 250,000 and 500,000 IU

 

Angikinase in pulmonary enbolism
Urokinase and the mode of action
F.A.Q. about Angikinase

 


© 2004 Sedico Co.All rights reserved
Designed and Developed by "EBM"